|
1
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Clarke MF, Dick JE, Dirks PB, et al:
Cancer stem cells - perspectives on current status and future
directions: AACR workshop on cancer stem cells. Cancer Res.
66:9339–9344. 2006. View Article : Google Scholar
|
|
3
|
Dalerba P, Cho RW and Clarke MF: Cancer
stem cells: models and concepts. Annu Rev Med. 58:267–284. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yin AH, Miraglia S, Zanjani ED, et al:
AC133, a novel marker for human hematopoietic stem and progenitor
cells. Blood. 90:5002–5012. 1997.PubMed/NCBI
|
|
5
|
Miraglia S, Godfrey W, Yin AH, et al: A
novel five-transmembrane hematopoietic stem cell antigen:
isolation, characterization, and molecular cloning. Blood.
90:5013–5021. 1997.PubMed/NCBI
|
|
6
|
Singh SK, Hawkins C, Clarke ID, et al:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Taylor MD, Poppleton H, Fuller C, et al:
Radial glia cells are candidate stem cells of ependymoma. Cancer
Cell. 8:323–335. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110.
2007.PubMed/NCBI
|
|
10
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Todaro M, Alea MP, Di Stefano AB, et al:
Colon cancer stem cells dictate tumor growth and resist cell death
by production of interleukin-4. Cell Stem Cell. 1:389–402. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eramo A, Lotti F, Sette G, et al:
Identification and expansion of the tumorigenic lung cancer stem
cell population. Cell Death Differ. 15:504–514. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma S, Chan KW, Hu L, et al: Identification
and characterization of tumorigenic liver cancer stem/progenitor
cells. Gastroenterology. 132:2542–2556. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Monzani E, Facchetti F, Galmozzi E, et al:
Melanoma contains CD133 and ABCG2 positive cells with enhanced
tumourigenic potential. Eur J Cancer. 43:935–946. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Curley MD, Therrien VA, Cummings CL, et
al: CD133 expression defines a tumor initiating cell population in
primary human ovarian cancer. Stem Cells. 27:2875–2883.
2009.PubMed/NCBI
|
|
16
|
Hermann PC, Huber SL, Herrler T, et al:
Distinct populations of cancer stem cells determine tumor growth
and metastatic activity in human pancreatic cancer. Cell Stem Cell.
1:313–323. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mizrak D, Brittan M and Alison MR: CD133:
molecule of the moment. J Pathol. 214:3–9. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shmelkov SV, Butler JM, Hooper AT, et al:
CD133 expression is not restricted to stem cells, and both
CD133+ and CD133- metastatic colon cancer
cells initiate tumors. J Clin Invest. 118:2111–2120.
2008.PubMed/NCBI
|
|
19
|
Horst D, Kriegl L, Engel J, Kirchner T and
Jung A: CD133 expression is an independent prognostic marker for
low survival in colorectal cancer. Br J Cancer. 99:1285–1289. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kojima M, Ishii G, Atsumi N, Fujii S,
Saito N and Ochiai A: Immunohistochemical detection of CD133
expression in colorectal cancer: A clinicopathological study.
Cancer Sci. 99:1578–1583. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kemper K, Sprick MR, de Bree M, et al: The
AC133 epitope, but not the CD133 protein, is lost upon cancer stem
cell differentiation. Cancer Res. 70:719–729. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Leibovitz A, Stinson JC, McCombs WB III,
McCoy CE, Mazur KC and Mabry ND: Classification of human colorectal
adenocarcinoma cell lines. Cancer Res. 36:4562–4569.
1976.PubMed/NCBI
|
|
23
|
Jaksch M, Múnera J, Bajpai R, Terskikh A
and Oshima RG: Cell cycle-dependent variation of a CD133 epitope in
human embryonic stem cell, colon cancer, and melanoma cell lines.
Cancer Res. 68:7882–7886. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kelm JM, Timmins NE, Brown CJ, Fussenegger
M and Nielsen LK: Method for generation of homogeneous
multicellular tumor spheroids applicable to a wide variety of cell
types. Biotech Bioeng. 83:173–180. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dertinger H and Hulser DF: Intercellular
communication in spheroids. Recent Results Cancer Res. 95:67–83.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sutherland RM: Cell and environment
interactions in tumor microregions: the multicell spheroid model.
Science. 240:177–184. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vaupel P, Kallinowski F and Okunieff P:
Blood flow, oxygen and nutrient supply, and metabolic
microenvironment of human tumors: a review. Cancer Res.
49:6449–6465. 1989.PubMed/NCBI
|
|
28
|
Griguer CE, Oliva CR, Gobin E, Marcorelles
P, Benos DJ, Lancaster JR and Gillespie GY: CD133 is a marker of
bioenergetic stress in human glioma. PLoS One. 3:e36552008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Du L, Wang H, He L, Zhang J, Ni B, Wang X,
Jin H, et al: CD44 is of functional importance for colorectal
cancer stem cells. Clin Cancer Res. 14:6751–6760. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Horst D, Scheel SK, Liebmann S, Neumann J,
Maatz S, Kirchner T and Jung A: The cancer stem cell marker CD133
has high prognostic impact but unknown functional relevance for the
metastasis of human colon cancer. J Pathol. 219:427–434. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kirkland SC: Type I collagen inhibits
differentiation and promotes a stem cell-like phenotype in human
colorectal carcinoma cells. Br J Cancer. 101:320–326. 2009.
View Article : Google Scholar : PubMed/NCBI
|
